Frostbite and Cold Agglutinin Disease: Coexistence of Two Entities Leading to Poor Clinical Outcomes.


Journal

Medicina (Kaunas, Lithuania)
ISSN: 1648-9144
Titre abrégé: Medicina (Kaunas)
Pays: Switzerland
ID NLM: 9425208

Informations de publication

Date de publication:
08 Jun 2021
Historique:
received: 06 05 2021
revised: 28 05 2021
accepted: 07 06 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 6 7 2021
Statut: epublish

Résumé

An 83-year-old woman was admitted to the emergency department for a 7-day history of fatigue and progressive cyanosis in the feet and hands after cold exposure despite physical protective measures. Upon arrival, the patient presented with necrotic cutaneous lesions in both hands and distal lower extremities. Upon admission, hemoglobin was 7.6 g/dL and laboratory tests were consistent with cold agglutinin disease (CAD), the presence of monoclonal IgM, and flow cytometry consistent with lymphoplasmacytic lymphoma, but MYD88 L265P mutation was negative. The patient required blood transfusion, resulting in stabilized hemoglobin and a decrease in markers of hemolysis. Treatment with aspirin 250 mg daily and intravenous iloprost 0.5 mL/h was initiated with a poor clinical response at day 4. Amputation was required. Plasma exchange was performed and chemotherapy with rituximab and bendamustine was initiated. The clinical course was marked by further necrosis, prompting discussions regarding an additional amputation that was not performed considering the high surgical risk and refusal by the patient. Supportive treatment was initiated, and the patient expired one month after hospital admission.

Identifiants

pubmed: 34201186
pii: medicina57060592
doi: 10.3390/medicina57060592
pmc: PMC8230137
pii:
doi:

Substances chimiques

Rituximab 4F4X42SYQ6
Aspirin R16CO5Y76E

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Références

Clin Lymphoma Myeloma. 2009 Mar;9(1):110-2
pubmed: 19362990
Haematologica. 2014 Mar;99(3):497-504
pubmed: 24143001
Br J Haematol. 2018 May;181(3):320-330
pubmed: 29363757
Blood. 2017 Jul 27;130(4):537-541
pubmed: 28533306
J Blood Med. 2019 Apr 09;10:93-103
pubmed: 31114413
J Spec Oper Med. 2020 Winter;20(4):123-135
pubmed: 33320326
Haematologica. 2006 Apr;91(4):460-6
pubmed: 16585012
CMAJ. 2017 Jun 5;189(22):E781
pubmed: 28584043

Auteurs

Noel Lorenzo-Villalba (N)

Service de Médecine Interne, Diabète et Maladies Métaboliques, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.

Emmanuel Andres (E)

Service de Médecine Interne, Diabète et Maladies Métaboliques, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.

Javier Guerrero-Niño (J)

Service des Urgences, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.

Edward Nasco (E)

Service de Médecine Interne, Diabète et Maladies Métaboliques, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.

Jessy Cattelan (J)

Service de Médecine Interne, Diabète et Maladies Métaboliques, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.

Xavier Jannot (X)

Service de Médecine Interne, Diabète et Maladies Métaboliques, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.

Marie-Pierre Ledoux (MP)

Service d'Hématologie, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH